MedTrace Logo

Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

NCT05477394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-07-28

No results posted yet for this study

Summary

SARS-COV-2 crisis is a severe public health concern in the world. It is now well recognized that older age, diabetes mellitus, obesity (BMI \> 30 kg/m2), and hypertension increase the risk of complications and death in SARS-COV-2 patients.

This study will describe the spectrum of clinical features, the likely pathophysiologic mechanisms, and potential implications for the management of metabolic syndrome in SARS-COV-2 patients.

Conditions

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • amr mo hilal · Ain Shams University

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-12-30
Completion
2022-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05477394 on ClinicalTrials.gov